Annual Drug Patent Expirations for ATORVALIQ
Atorvaliq is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in ATORVALIQ is atorvastatin calcium. One supplier is listed for this compound. Additional details are available on the atorvastatin calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
